Skip to content

PARALLAX HEALTH SCIENCES, INC.: 10-Q filed 2015-08-24

What PARALLAX HEALTH SCIENCES, INC. reported in its quarterly report filed 2015-08-24 (fiscal Q2 2015): 19 published measures, 48 facts as tagged in accession 0001388410-15-000025.

This filing

Form
10-Q (quarterly report)
Filed
2015-08-24
Fiscal period
fiscal Q2 2015
Accession
0001388410-15-000025 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All PARALLAX HEALTH SCIENCES, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-3026,012USD
At 2014-12-3127,960USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2015-06-302,002,450USD
At 2014-12-311,501,458USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-06-302,475USD
At 2014-12-31513USD
At 2014-06-30193USD
At 2013-12-31569USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-36,018USD181
2014-01-01 to 2014-06-30-376USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2015-01-01 to 2015-06-3037,980USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-06-306,449USD
At 2014-12-319,527USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-148,774USD91
2015-01-01 to 2015-06-30-286,436USD181
2014-04-01 to 2014-06-30-110,683USD91
2014-01-01 to 2014-06-30-222,026USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-302,475USD
At 2014-12-31513USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-126,164USD91
2015-01-01 to 2015-06-30-250,574USD181
2014-04-01 to 2014-06-30-27,468USD91
2014-01-01 to 2014-06-30-32,549USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-302,002,450USD
At 2014-12-311,501,458USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2015-06-3017,088USD
At 2014-12-3117,920USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-06-30132,026,053shares
At 2014-12-31128,228,018shares

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2015-06-30-1,976,438USD
At 2014-12-31-1,473,498USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-276,893USD91
2015-01-01 to 2015-06-30-540,920USD181
2014-04-01 to 2014-06-30-97,568USD91
2014-01-01 to 2014-06-30-258,569USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30148,774USD91
2015-01-01 to 2015-06-30286,436USD181
2014-04-01 to 2014-06-30110,683USD91
2014-01-01 to 2014-06-30222,026USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2015-01-01 to 2015-06-303,078USD181
2014-01-01 to 2014-06-303,162USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2015-01-01 to 2015-06-30832USD181
2014-01-01 to 2014-06-30832USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-128,119USD91
2015-01-01 to 2015-06-30-254,484USD181
2014-04-01 to 2014-06-3013,115USD91
2014-01-01 to 2014-06-30-36,543USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2015-01-01 to 2015-06-3037,980USD181

Inspect the source

Entity
PARALLAX HEALTH SCIENCES, INC. / CIK 0001388410
Captured
SEC response SHA-256
94ef7b5cf30837ee48a9b3f8b759fe12b3da087f5b0a8ff4d38505bc8677ecf0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001388410.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))